Ultragenyx grants 44,409 RSUs to new hires under Nasdaq rule
Ultragenyx Pharmaceutical Inc. granted 44,409 restricted stock units to 15 newly hired non-executive officers as an employment inducement under Nasdaq Listing Rule 5635(c)(4). The awards, approved by the compensation committee, vest over four years with 25% vesting annually starting from the grant date of June 16, 2026.
*this image is generated using AI for illustrative purposes only.
Ultragenyx Pharmaceutical Inc. granted 44,409 restricted stock units of its common stock to 15 newly hired non-executive officers as an inducement material to their employment. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan. The grant date was June 16, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).
The restricted stock units vest over four years, with 25% of the underlying shares vesting on each anniversary of the grant date. Vesting is subject to the employee being continuously employed by the company as of such vesting dates.
Grant Details
| Detail | Information |
|---|---|
| Total RSUs Granted | 44,409 |
| Recipients | 15 newly hired non-executive officers |
| Grant Date | June 16, 2026 |
| Vesting Schedule | 25% annually over four years |
| Governing Rule | Nasdaq Listing Rule 5635(c)(4) |
Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases. The company’s strategy is predicated upon time- and cost-efficient drug development to deliver safe and effective therapies to patients with high unmet medical needs.
What specific roles or expertise do these 15 new hires bring to Ultragenyx's pipeline?
How will the dilution from these RSUs impact existing shareholders over the next four years?
Does this hiring surge indicate an acceleration in clinical trials or expansion into new therapeutic areas?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
